Andrew Partridge

Corporate Officer/Principal bij TURG POIN

55 jaar

Health Technology

Actieve functies van Andrew Partridge

Bedrijven	Functie	Begin	Einde
TURG POIN	Corporate Officer/Principal	13-07-2020	-

Bedrijven	Functie	Begin	Einde
CENTREXION THERAPEUTICS CORPORATION	Corporate Officer/Principal	24-09-2018	02-07-2020
VERTEX PHARMACEUTICALS INCORPORATED	Corporate Officer/Principal	01-01-2013	01-11-2018
AMGEN INC.	Verkoop & Marketing	01-01-2003	01-01-2013

Internationaal

Verenigde Staten

Operationeel

Corporate Officer/Principal	3
Sales & Marketing	1

Sectoraal

Health Technology

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	2
VERTEX PHARMACEUTICALS INCORPORATED	Health Technology
AMGEN INC.	Health Technology

Bedrijven in privébezit	2
Centrexion Therapeutics Corp. Centrexion Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Centrexion Therapeutics Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, developing, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of chronic pain. Its product pipeline includes CNTX-4975, CNTX-0290, CNTX-6970, CNTX-2022, CNTX-6016, and intrathecal platform. The company was founded by Sol J. Barer and Jeffrey B. Kindler in February 2013 and is headquartered in Boston, MA.	Health Technology
Turning Point Therapeutics, Inc. Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA.	Health Technology

Bedrijven in privébezit

Health Technology